(Q43981584)
Statements
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study) (English)
Patrizia Sola
Marinella Clerico
Irene Schiavetti
Stefania F De Mercanti
Federico Piazza
Dario Gned
Vincenzo Brescia Morra
Anna Bianchi
Sabrina Realmuto
Francesca Vitetta